Skip to main content
SpringerLink
Log in

Heart failure and angiotensin-converting enzyme inhibitors

Is there a need for specialty care?

  • Editorials
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Guidelines for the evaluation and management of heart failure. J Am Coll Cardiol. 1995;26:1376–98.

    Article  Google Scholar 

  2. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med. 1991;325:293–302.

    Article  Google Scholar 

  3. The SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med. 1992;327:686–91.

    Google Scholar 

  4. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992; 327:669–77.

    Article  PubMed  CAS  Google Scholar 

  5. Young JB, Weiner DH, Yusuf S, et al. Patterns of medication use in patients with heart failure: a report from the registry of studies of left ventricular dysfunction (SOLVD). South Med J. 1995;88:514–23.

    PubMed  CAS  Google Scholar 

  6. Bourassa MG, Gurne O, Bangdiwala SI, et al. Natural history and patterns of current practice in heart failure. J Am Coll Cardiol. 1993;22:14–9A.

    Article  Google Scholar 

  7. Chin MH, Wang JC, Žhang JX, Lang RM. Utilization and dosing of angiotensin converting enzyme inhibitors for heart failure: effect of physician specialty and patient characteristics. J Gen Intern Med. 1997;12:563–6.

    Article  PubMed  CAS  Google Scholar 

  8. Packer M. Do angiotensin converting enzyme inhibitors prolong life in patients with heart failure treated in clinical practice? J Am Coll Cardiol. 1996;28:1323–7.

    Article  Google Scholar 

  9. Chin MH, Friedmann PD, Cassel CK, Lang RM. Differences in generalist and specialist knowledge and use of angiotensin converting enzyme inhibitors for congestive heart failure. J Gen Inter Med. 1997;12:523–30.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiovascular Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia

    Marc A. Scheiner MD & Stephen E. Kimmel MD, MS

  2. Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia

    Stephen E. Kimmel MD, MS

Authors
  1. Marc A. Scheiner MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stephen E. Kimmel MD, MS
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Scheiner, M.A., Kimmel, S.E. Heart failure and angiotensin-converting enzyme inhibitors. J GEN INTERN MED 12, 581–582 (1997). https://doi.org/10.1046/j.1525-1497.1997.07147.x

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1046/j.1525-1497.1997.07147.x

Search

Navigation